Essity AB Class A · OMXSTO:ESSITY_A
Essity AB Class A — Non-Deal Roadshow (February 2024)
27 slides from Essity AB Class A's roadshow presentation, Feb 6, 2024

Slide 1: The Essity Group
The Essity Group Fredrik Rystedt Executive Vice President and CFO

Slide 2: Forward-looking statements
This presentation may contain forward-looking statements. Such statements are based on our current expectations and are subject to certain risks and uncertainties that could negatively affect our business. Please read our most recent annual and sustainability report for a better understanding of the

Slide 3: Oslo Roadshow with DNB February 6, 2024
Oslo Roadshow with DNB February 6, 2024 3

Slide 4: Essity – A Global, Leading Hygiene and Health Company
Essity – A Global, Leading Hygiene and Health Company Net sales 2023 147.1 SEKbn 18.9 Adjusted EBITA 2023 SEKbn 36,000 employees Oslo Roadshow with DNB 4

Slide 5: Three Attractive Business Areas
Three Attractive Business Areas Health & Medical Consumer Goods Professional Hygiene Health & Medical Consumer Goods Professional Hygiene Personal and home hygiene Hygiene management for all stages of life solutions for a broad set of commercial applications Oslo Roadshow with DNB February 6, 2024 5

Slide 6: Leading Global Market Positions
Leading Global Market Positions Health & Medical Consumer Goods Professional Hygiene Incontinence Products Health Care #1 Incontinence Products Retail #2 Professional Hygiene #1 Compression Therapy #1 Consumer Tissue #3 Orthopedics #3 Feminine Care #5 Wound Care #5 Baby Care #5 Position #1 or #2 ~90

Slide 7: Favorable Market Trends
Favorable Market Trends Growing and Aging Population Prevalence of Awareness about Chronic Conditions Text Increased Disposable Income Hygiene and Health Sustainability and Higher Living Standards Digitalization

Slide 8: Key Achievements 2023
Key Achievements 2023 Highest profit ever and strong platform for growth Substantially improved structural margins for all business areas Good progress on key priorities – innovation, efficiency and sustainability Pre-conditional public offer announced for the shares in Vinda – enabling more attract

Slide 9: Pre-conditional Public Offer Announced for 100% of Shares in Vinda
Pre-conditional Public Offer Announced for 100% of Shares in Vinda Attractive offer yielding an annual return on the investment of approx. 14% at an EV/EBITDA multiple of 18.1x ▪ Isola Castle Ltd has announced that it will make a pre-conditional public offer to acquire 100% of Vinda for a price per

Slide 10: Net Sales Split 2023
Net Sales Split 2023 By Business Area and Category By Region Other, 4% Health & Asia, 2% Professional Medical, 19% Hygiene, 27% Incontinence Products Latin Health Care 11% Medical America, Solutions 17% 8% Europe, Baby Care 60% 5% Incontinence Consumer North Products Retail Tissue America, 7% Femini

Slide 11: Long-term Portfolio Direction
Long-term Portfolio Direction Health & Medical Professional Hygiene Consumer Personal Tissue Care Consumer Goods 11

Slide 12: Value Creating Acquisitions
Value Creating Acquisitions Text

Slide 13: Clear Long-term Financial Targets and Capital Allocation Priorities
Clear Long-term Financial Targets and Capital Allocation Priorities Maintain Annual sales growth1) Capital structure a solid >5% Baa1 long-term rating from investment grade rating Moody’s and BBB+ from S&P Adjusted return on capital employed2) Dividend >17% Dividend policy aiming for stable and risi

Slide 14: 2023 - Strong Sales Growth, Record High Adjusted EBITA
2023 - Strong Sales Growth, Record High Adjusted EBITA Adjusted Adjusted +0.9% 147,147 EBITA2) EBITA Margin2) +9.5% Acquisitions SEK 12.8% 18,898m +360bps 131,320 -3.7% +57% Volume Price/Mix Adjusted Adjusted Earnings ROCE2) per Share3) Sales Growth1) +6.7% SEK 16.4% Net Sales Reported Growth: +12.1

Slide 15: Strong Development of Sales and Profits
Strong Development of Sales and Profits Net Sales Adjusted EBITA1) SEKbn SEKbn +45% +65% 147.1 18.9 131.3 101.5 12.0 11.5 2021 2022 2023 2021 2022 2023 Sales Adjusted Growth2) +4.0% +19.7% +6.7% EBITA Margin1) +11.3% +9.2% +12.8% 1) Excluding items affecting comparability 2) Including organic sales

Slide 16: Strong Development of Sales and Profits
Strong Development of Sales and Profits Net Sales Adjusted EBITA1) 18.9 147.1 17.6 SEKbn 131.3 SEKbn 129.0 15.8 118.5 121.8 109.3 13.4 12.9 98.5 101.2 101.5 12.0 11.5 12.0 88.0 10.6 9.5 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Adjusted Sales

Slide 17: Dividend SEK 7.75
Dividend 7.751) 7.25 7.00 Proposed Dividend1) 6.75 6.25 5.75 SEK 7.75 +7% 2018 2019 2020 2021 2022 2023 1) Board of Directors Proposal Oslo Roadshow with DNB February 6, 2024 17

Slide 18: Progress on Key Priorities
Progress on Key Priorities 2023 Growth in Fastest Innovation & Growing Leading in Price Management Cost Efficiency Brands Categories and Sustainability Channels Science Based Targets +8.9% in Price +0.6% in Mix SEK 433m Inco Retail +14% Scope 1 and 2 vs 2016 Strong price effect while still Growth in

Slide 19: Committed to Sustainable Solutions
Committed totoSustainable Committed Solutions andSolutions Sustainable Net Zero and Emissions by 2050 Net Zero Emissions by 2050 19

Slide 20: Tork PeakServe with 20+ patents
Tork PeakServe with 20+ patents Highest 250% More capacity2 capacity on the market1 50% 1/2 Compression of towels Cut refill time in half2 1) Compared to competitor's longest roll towel in North America 2) Compared to Tork Universal refills and folded towel dispenser

Slide 21: Feminine Care
Feminine Care 21

Slide 22: Accelerate Sustainable Solutions
Accelerate Sustainable Solutions 3Rs 3Rs Reduce Reuse Recycle

Slide 23: Superiority
Superiority Share of Net Sales with Superiority 62% 56% 40% 2017 2020 2023 Oslo Roadshow with DNB

Slide 24: Priorities 2024
Priorities 2024 Strong platform for growth ▪ Volume growth in high yielding segments Professional ▪ Innovation, brands and market shares gains Hygiene ▪ Price management ▪ Operational efficiency and digitalization ▪ Continued progress on ESG Oslo Roadshow with DNB

Slide 25: Reasons to Invest in Essity
Reasons to Invest in Essity Fundamentally attractive market Market leading brands Sustainability at the core Clear value creating strategy Attractive financial profile Proven execution Oslo Roadshow with DNB

Slide 26: Q&A
Q&A Text

Slide 27
Source: Internet Archive copy of essity.com
More decks from Essity AB Class A
Q3 2026 Earnings Presentation28 slides · Oct 22, 2026
Q2 2026 Earnings Presentation20 slides · Jul 16, 2026
Investor Day (May 2026)122 slides · May 7, 2026
Q1 2026 Earnings Presentation20 slides · Apr 23, 2026
Q4 2025 Earnings Presentation22 slides · Jan 22, 2026
Q3 2025 Earnings Presentation17 slides · Oct 23, 2025